Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients with Cardiovascular Disease: AIM HIGH Trial

BACKGROUND AND PURPOSE: In AIM-HIGH addition of extended-release niacin (ERN) to simvastatin in participants with established CV disease, low HDL-C and high triglycerides, there was no incremental benefit despite increases in HDL-C, preliminary analysis based on incomplete endpoint adjudication sugg...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stroke
Autors principals: Teo, Koon K., Goldstein, Larry B., Chaitman, Bernard R., Grant, Shannon, Weintraub, William S., Anderson, David C., Sila, Cathy A., Cruz-Flores, Salvador, Padley, Robert J., Kostuk, William J., Boden, William E.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4886540/
https://ncbi.nlm.nih.gov/pubmed/23881958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.113.001529
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars